Results 101 to 110 of about 1,087 (181)

Effect of Concomitant Medications on Adverse Event Frequency, Severity, and Time to Resolution in a Cenobamate Open-Label Trial. [PDF]

Eur J Neurol
Steinhoff BJ, Gil-Nagel A, Alvarez-Baron E, Leach JP, Thangavelu K, Winter Y, Villanueva V.   +6 more
europepmc   +1 more source

Cenobamate for Difficult-to-Treat Epilepsy – Selected Case Vignettes

Neuropsychiatric Disease and Treatment
Flavio Villani,1 Fedele Dono,2 Francesca Felicia Operto,3 Pietro Pignatta,4 Monica Puligheddu,5 Carlotta Stipa,6 Tiziano Zanoni7 1Division of Clinical Neurophysiology and Epilepsy Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy; 2Department
Villani F, Dono F, Operto FF, Pignatta P, Puligheddu M, Stipa C, Zanoni T   +6 more
doaj  

Cognitive Impairment in Drug-Resistant Epilepsy: A Multidomain Systematic Review. [PDF]

Brain Sci
Bargielski M, Adamska-Patruno E, Krętowski A, Kochanowicz J, Kułakowska A, Chorąży M.   +5 more
europepmc   +1 more source

The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant Epilepsy. [PDF]

CNS Drugs
Choi YM, White HS, Klein P, Löscher W.
europepmc   +1 more source

Effect of Fenfluramine on convulsive seizures and rescue medication usage: A case series of adults within the Lennox-Gastaut syndrome spectrum. [PDF]

Epilepsy Behav Rep
Chilson L, Zaaimi B, Samarasekera S.
europepmc   +1 more source

Redefining the treatment pathway for medication-resistant epilepsy in the cenobamate era: Surgical obviation or surgical delay. [PDF]

Epilepsia
Kerr WT, McFarlane KN.
europepmc   +1 more source

Delayed and deferred surgery associated with cenobamate use in people with drug-resistant focal epilepsy. [PDF]

Epilepsia
Pellinen J, Sillau S, Bui A, Danciutiu A, Kaye L, Sood A, Ferrari L, Rosenfeld WE, Elder C.   +8 more
europepmc   +1 more source

Effectiveness and safety of cenobamate after conversion to monotherapy or dual therapy in real-world clinical practice. [PDF]

Epileptic Disord
Benavente ÁS, Martín GG, Ruiz EDC, García PC, Moreno YL, María JCE, Fuentes IL, Conti SN, Calle RC, Cabrera AF, González IR, Blanco DC, Muñoz MIC, Castro PJS.   +13 more
europepmc   +1 more source

The Complexity and Challenges of Developing Effective Epilepsy Therapies: Lessons to be Learned from Comparing Cenobamate, Carisbamate, and Padsevonil. [PDF]

CNS Drugs
Löscher W, White HS, Klein P.
europepmc   +1 more source

Improving the tolerability of antiseizure medications: When and how to use cenobamate and other new antiseizure medications

Despite the introduction of newer antiseizure medications (ASMs) with improved safety profiles over the past several years, rates of treatment-related intolerable adverse events (AEs) for people with epilepsy have not changed substantially.
Rosenfeld, William E, Krauss, Gregory L, Sander, Josemir W   +2 more
core